Fusion Pharmaceuticals Inc. Operating Loss Carryforwards
Fusion Pharmaceuticals Inc. had Operating Loss Carryforwards of $170.20 million as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2023-03-16
- 2022-12-31: Operating Loss Carryforwards $170.20M.
- 2021-12-31: Operating Loss Carryforwards $102.60M.
- 2020-12-31: Operating Loss Carryforwards $46.20M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2022-12-31 | $170.20M 10-K · filed 2023-03-16 |
| 2021-12-31 | $102.60M 10-K · filed 2022-03-17 |
| 2020-12-31 | $46.20M 10-K · filed 2021-03-25 |